Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733]
1 Department of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, Buffalo, NY.
2 Department of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, Buffalo, NY; For-Robin, Inc., Buffalo, NY; Department of Microbiology and Immunology, University at Buffalo, Buffalo, NY.
3 Department of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, Buffalo, NY; For-Robin, Inc., Buffalo, NY.
4 For-Robin, Inc., Buffalo, NY.
5 Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO; Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, MO.
6 Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO; Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO.
7 Goodwin Biotechnology, Inc., Plantation, FL.
8 Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY.
9 Department of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, Buffalo, NY; For-Robin, Inc., Buffalo, NY. Electronic address: krolson@buffalo.edu.